Some commercially insured patients stand to save $150 per month on Wegovy, a popular obesity medication. Patients on Medicare ...

Zepbound contains the same active ingredient, tirzepatide, as Mounjaro, which is also made by Lilly and is FDA-approved to treat Type 2 diabetes. Some doctors also prescribe Mounjaro "off-label" for ...

Who is eligible for both Medicare and Medicaid in California? Beneficiaries with dual eligibility Wegovy has gained attention as a powerful weight loss medication, especially for those struggling ...

Novo Nordisk is providing direct-to-patient delivery of Wegovy (semaglutide) through the NovoCare Pharmacy program.

After Zepbound-maker Eli Lilly reduced the price of the weight-loss drug, competitor Novo Nordisk has cut the price of weight ...

Novo Nordisk’s weight loss drug Wegovy is linked to an increased risk of hair loss, a study suggests. Meanwhile, Dexcom ...

The FDA has approved Wegovy and Mounjaro for the following uses in adults: Doctors prescribe Wegovy together with diet and exercise ... depends on the treatment plan your doctor prescribes ...

Adults with obesity who have a prescription for Wegovy but do not have insurance coverage for the drug can now purchase the ...

Novo Nordisk spokesperson Jamie Bennett said the company plans to extend the $499 price to cash-paying customers at other pharmacies "in the near future." The list price for Wegovy remains at $ ...